4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034424
Chief Financial Officer sold 3,616 shares at $14.55 ($52,613)
From the SEC's structured data for this filing
Trades in this filing
Koppikar Utpal · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Sale : show line 1 in the form | −3,616 | $14.55 | $52,613 | 168,966 | D |
| Open-market sales · 3,616 sh · avg $14.55 · $52,613 | ||||||
Loading xslF345X03/doc4.xml…